- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04118023
7T MRI to Evaluate Cartilage Defects in the Knee
February 5, 2025 updated by: Patrick McCulloch,MD, The Methodist Hospital Research Institute
Improving Non-Invasive Diagnosis and Grading of Cartilage Defects in the Knee - Accuracy of Ultra High Field 7-Tesla MRI as Compared With Arthroscopy
The investigators propose to prospectively evaluate the accuracy of a novel 7-Tesla (7T) knee MRI protocol for the detection and grading of cartilage lesions in the knee, which is a significant limitation of current MRI techniques.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The investigators hypothesize that 7T MRI will be ~ 80% sensitive for detection of cartilaginous lesions.
This will be tested in a prospective multi-reader study of 100 patients who are scheduled to have knee arthroscopy.
Patients will have two MRIs of the knee: one standard of care and one experimental 7T MRI.
Subjects will visit at one time point prior to scheduled knee arthroscopy, for a session time of ~1-2 hours for a single 7T MRI scan.
Study Type
Observational
Enrollment (Actual)
112
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Houston Methodist Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients of a single surgeon in an outpatient clinic.
Description
Inclusion Criteria:
- Confirmed Knee Symptomatology
- Scheduled Arthroscopic Treatment of Knee
- Adult (equal or greater than 18 years of age)
Exclusion Criteria:
- Active infections
- Less than 18 years of age
- Pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
7T MRI Group
Patient group that receives 7 Tesla Magnetic Resonance Imaging
|
MAGNETOM Terra - 7T MRI Scanner by Siemens Healthineers.
Each patient enrolled will undergo the study imaging test prior to planned diagnostic knee arthroscopy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Whole-Organ Magnetic Resonance Imaging Score (WORMS)
Time Frame: baseline
|
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Susan Miller, MD, MPH, The Methodist Hospital Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2019
Primary Completion (Actual)
August 19, 2021
Study Completion (Actual)
September 7, 2022
Study Registration Dates
First Submitted
October 4, 2019
First Submitted That Met QC Criteria
October 4, 2019
First Posted (Actual)
October 7, 2019
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 5, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00022554
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Injuries
-
Mayo ClinicCompletedArthroplasty, Replacement, Knee | Injuries, KneeUnited States
-
Wake Forest University Health SciencesTerminatedInjuries, KneeUnited States
-
Poitiers University HospitalWithdrawn
-
Michigan Technological UniversityBlue Cross Blue Shield of Michigan FoundationActive, not recruitingKnee Osteoarthritis | Knee Injuries | Knee ArthritisUnited States
-
Universidad de ZaragozaUnknownAnterior Cruciate Ligament Injuries | Injuries, Knee | Prevention & ControlSpain
-
Bahçeşehir UniversityCalifornia State University, Long BeachRecruitingInjury, Knee | Valgus Deformity, Not Elsewhere Classified, KneeUnited States
-
University Aleksander Moisiu DurresCompletedKnee Injuries | Knee Injuries, Sport InjuryAlbania
-
Tissue Regenix LtdRecruiting
-
Istituto Ortopedico RizzoliCompletedStiffness of Knee, Not Elsewhere Classified | Knee FracturesItaly
-
University of PennsylvaniaCompletedSurgery | Opioid Use | Orthopedic Surgery | Neurosurgery | Acute Injuries KneeUnited States
Clinical Trials on 7 Tesla Magnetic Resonance Imaging Test
-
Assistance Publique Hopitaux De MarseilleUnknown
-
University of CambridgeCambridge University Hospitals NHS Foundation Trust; Wolfson Brain Imaging...RecruitingCerebral Small Vessel Diseases | Cerebral Small Vessel Ischemic Disease | Lacunar StrokeUnited Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGlioma | Metastatic Malignant Solid Neoplasm | Central Nervous System Neoplasm | Metastatic Malignant Neoplasm in the Central Nervous SystemUnited States
-
IRCCS Eugenio MedeaCompletedEpilepsies, Partial | Epilepsy IntractableItaly
-
University of CincinnatiActive, not recruitingProstate CancerUnited States
-
Assistance Publique Hopitaux De MarseilleUnknownPremature ChildbirthFrance
-
Institut de Cancérologie de LorraineCompleted
-
Oslo University HospitalCompletedSurgery | Transposition of Great VesselsNorway